These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 4559161)

  • 41. [Experimental investigations on drug induced improvement of brain metabolism].
    Köhler W
    Wien Klin Wochenschr; 1972 May; 84(21):340-3. PubMed ID: 5064086
    [No Abstract]   [Full Text] [Related]  

  • 42. ["Extracoronary" effect of carbochromen on the circulation].
    Votcal BE; Zmurkin VP; Rogunov GA; Trosina TP; Alijeva ZM
    Arzneimittelforschung; 1970 Mar; 20():442-6. PubMed ID: 5468727
    [No Abstract]   [Full Text] [Related]  

  • 43. [Use of bamethan in the emergency treatment of cerebral disorders].
    Lotto A; Cantono GM; Cavallaro GF
    Arch Sci Med (Torino); 1971; 128(4):210-20. PubMed ID: 4404000
    [No Abstract]   [Full Text] [Related]  

  • 44. [Acute arrest of the retinal circulation eliminated by intravenous administration of Complamin].
    Thomalske G; Manz R
    Med Klin; 1967 Jan; 62(3):98 passim. PubMed ID: 6031752
    [No Abstract]   [Full Text] [Related]  

  • 45. [Clinical studies on the effect of a phospholipid complex from cattle brain in cerebral circulation disorders].
    Cloetens W; Cretallaz JC; Depaepe A; Bertholet G
    Med Welt; 1970 Mar; 12():510-5. PubMed ID: 5462778
    [No Abstract]   [Full Text] [Related]  

  • 46. [Muscular blood flow during inhibition of 3', 5'-AMP-phosphodiesterase. Clinical and experimental studies using 3,7-dimethyl-1-(5-oxo-hexyl)-xanthine].
    Köhler M
    Arzneimittelforschung; 1973 Apr; 23(4):566-70. PubMed ID: 4351130
    [No Abstract]   [Full Text] [Related]  

  • 47. [Polygraphic evaluation of a new vasoactive drug (nicergoline)].
    Baturic P; Cirignotta F
    Minerva Cardioangiol; 1973 Oct; 21(10):664-7. PubMed ID: 4589189
    [No Abstract]   [Full Text] [Related]  

  • 48. [Effect of intravenous administration of noradrenaline and angiotensin on blood supply to the brain, kidneys, intestine and hindlimbs of cats].
    Beketov AI; Demchenko IT; Korneliuk IK; Moskalenko IuE
    Fiziol Zh SSSR Im I M Sechenova; 1981 Aug; 67(8):1245-50. PubMed ID: 7286339
    [No Abstract]   [Full Text] [Related]  

  • 49. [Modification of cerebrovascular diseases through the oral administration of raubasine].
    Klein K; Grübl M
    Wien Med Wochenschr; 1974 Jun; 124(23):360-4. PubMed ID: 4599577
    [No Abstract]   [Full Text] [Related]  

  • 50. [Analysis of 3,7-dimethyl-1-(5-oxo-hexyl)-xanthine. 1. Spectroscopy of 3,7-dimethyl-1-(5-oxo-hexyl)-xanthine].
    Hinze HJ
    Arzneimittelforschung; 1971 Oct; 21(10):1456-9. PubMed ID: 5171860
    [No Abstract]   [Full Text] [Related]  

  • 51. [Analysis of the effect of Hydergin in long-term trial. An interdisciplinary study].
    Herzfeld U; Christian W; Oswald WD; Ronge J; Wittgen M
    Med Klin; 1972 Sep; 67(35):1118-25. PubMed ID: 4627270
    [No Abstract]   [Full Text] [Related]  

  • 52. [Effect of aminalon electrophoresis on brain bioelectrical activity in cerebral atherosclerosis patients with disordered cerebral blood circulation].
    Danilova IN; Neretin VIa; Nesterova LA
    Vopr Kurortol Fizioter Lech Fiz Kult; 1980; (4):13-7. PubMed ID: 7415011
    [No Abstract]   [Full Text] [Related]  

  • 53. Effect of proxazole on total and regional cerebral blood flow.
    Heiss WD; Prosenz P; Bruck J
    Arzneimittelforschung; 1973 Jun; 23(6):772-5. PubMed ID: 4579949
    [No Abstract]   [Full Text] [Related]  

  • 54. [Cerebral circulatory improvers and metabolic activators].
    Otomo E
    No To Shinkei; 1994 Mar; 46(3):239-44. PubMed ID: 8192938
    [No Abstract]   [Full Text] [Related]  

  • 55. [Effect of stugeron on cerebral hemodynamics in patients with disorders of the cerebral circulation].
    Iarullin KhKh; Khadzhiev D; Peniazeva GA; Levchenko NI
    Klin Med (Mosk); 1972 Jan; 50(1):62-9. PubMed ID: 5020032
    [No Abstract]   [Full Text] [Related]  

  • 56. [Cerebral circulatory and metabolic improver].
    Otomo E
    Nihon Rinsho; 1993 Nov; 51 Suppl():202-8. PubMed ID: 8283667
    [No Abstract]   [Full Text] [Related]  

  • 57. [Study of cerebral blood flow in softening of the brain].
    Billet R; Creissard P; Lahellec M
    Neurochirurgie; 1968 Dec; 14(9):957-69. PubMed ID: 4888224
    [No Abstract]   [Full Text] [Related]  

  • 58. [On the demonstration of drug effects on the brain circulation].
    Klein K
    Med Welt; 1967 Sep; 35():2021-5. PubMed ID: 5595992
    [No Abstract]   [Full Text] [Related]  

  • 59. The effect of cyclandelate on cerebral circulation. A double blind trial with clinical and radiocirculographic investigations.
    Eichhorn O
    Vasc Dis; 1965 Nov; 2(6):305-15. PubMed ID: 5323511
    [No Abstract]   [Full Text] [Related]  

  • 60. [Recent advances in brain metabolic activators].
    Ohtomo E
    No To Shinkei; 1984 Jul; 36(7):619-32. PubMed ID: 6386014
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.